Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research

Potter, V.T.; Iacobelli, S.; Biezen, A. van; Maertens, J.; Bourhis, J.H.; Passweg, J.R.; ... ; Kroger, N. (2016)

Article / Letter to editor

• Stem cell transplantation
• Myelodysplastic syndrome
• Chemotherapy
• Azacitidine

• All authors: Potter, V.T.; Iacobelli, S.; Biezen, A. van; Maertens, J.; Bourhis, J.H.; Passweg, J.R.; Yakhoub-Agha, I.; Tabrizi, R.; Bay, J.O.; Chevallier, P.; Chalandon, Y.; Huynh, A.; Cahn, J.Y.; Ljungman, P.; Craddock, C.; Lenhoff, S.; Russell, N.H.; Fegueux, N.; Socie, G.; Benedetto, B.; Meijer, E.; Mufti, G.J.; Witte, T. de; Robin, M.; Kroger, N.
• Date: 2016-09-30
• Journal: Biology of Blood and Marrow Transplantation
• Volume: 22
• Issue: 9
• Pages: 1615 - 1620
• DOI: doi:10.1016/j.bbmt.2016.05.026